Anti-F1 gene therapy (REYON Pharmaceutical Co Ltd/Neo Gene Pharm)

N/A

Report date: 2026/03/05 17:51:57

Base Information

Drug NameAnti-F1 gene therapy (REYON Pharmaceutical Co Ltd/Neo Gene Pharm)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionTripartite motif-containing protein 24 inhibitors
TargetsTripartite motif-containing protein 24
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReyon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeo Gene PharmReyon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A